Once-daily glucocorticoid treatment improves QOL in patients with adrenal insufficiency

659 Views

eMediNexus 02 January 2018

A study reported online December 8, 2017 in The Lancet Diabetes-Endocrinology suggests that a once-daily, modified-release glucocorticoid regimen may reduce the recurrent infections and metabolic effects that can occur with multiple daily doses in patients with adrenal insufficiency and improve their quality of life (QOL).

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.